作为上市后研究知情同意一部分的经济关联。美国医生和患者的态度。
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients.
作者信息
La Puma J, Stocking C B, Rhoades W D, Darling C M, Ferner R E, Neuberger J, VandenBurg M, Dews I, Tobias J S
机构信息
Center for Clinical Medical Ethics, University of Chicago, IL 60637, USA.
出版信息
BMJ. 1995 Jun 24;310(6995):1660-3. doi: 10.1136/bmj.310.6995.1660.
Abstract
Postmarketing research, often called phase IV trials, is intended to familiarise doctors and patients with newly approved drugs. La Puma and colleagues, in Chicago, studied doctors' and patients' attitudes to whether doctors should receive payment for taking part in such research. We asked for commentaries on their findings from four ethical experts, who put the study in a British context, present the views of patients, and examine some methodological assumptions.
摘要
上市后研究，通常称为IV期试验，旨在让医生和患者熟悉新批准的药物。芝加哥的拉普马及其同事研究了医生和患者对于医生参与此类研究是否应获得报酬的态度。我们邀请了四位伦理专家对他们的研究结果发表评论，这些专家将该研究置于英国背景下，阐述了患者的观点，并审视了一些方法学假设。
相似文献
1
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients.作为上市后研究知情同意一部分的经济关联。美国医生和患者的态度。
BMJ. 1995 Jun 24;310(6995):1660-3. doi: 10.1136/bmj.310.6995.1660.
2
Should informed consent include information on how research is funded?
IRB. 1991 Sep-Oct;13(5):1-3.
3
The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals.从患者、公众和医疗保健专业人员角度看随机对照试验的伦理问题
BMJ. 1998 Oct 31;317(7167):1209-12. doi: 10.1136/bmj.317.7167.1209.
4
"How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research.“如果我做志愿者，能得到多少报酬？”关于奖励、同意和研究的机构政策建议。
Hosp Health Serv Adm. 1994 Summer;39(2):193-203.
5
Danish patients' attitudes to scientific-ethical questions. An interview study focusing therapeutic trials.
Acta Med Scand. 1984;215(2):99-104. doi: 10.1111/j.0954-6820.1984.tb04978.x.
6
Do we need informed consent?
Lancet. 1986 Oct 18;2(8512):911-2. doi: 10.1016/s0140-6736(86)90425-3.
7
The limits of disclosure: what research subjects want to know about investigator financial interests.披露的限度：研究对象想了解的关于研究者经济利益的情况。
J Law Med Ethics. 2006 Fall;34(3):592-9, 481. doi: 10.1111/j.1748-720x.2006.00073.x.
8
Informed consent--help or hindrance.知情同意——助力还是阻碍。
J R Soc Med. 1990 Oct;83(10):603-6. doi: 10.1177/014107689008301002.
9
Information in the ICU: are we being honest with our patients? The results of a European questionnaire.重症监护病房中的信息：我们是否对患者坦诚相待？一项欧洲问卷调查的结果。
Intensive Care Med. 1998 Dec;24(12):1251-6. doi: 10.1007/s001340050758.
10
Promotion of ethics in gastroenterology: joint meeting of the members of JSGE and OMGE.促进胃肠病学领域的伦理道德：日本胃肠病学会（JSGE）和欧洲胃肠病学和内镜学会（OMGE）成员联席会议
Gastroenterol Jpn. 1993 Jul;28(Suppl. 6):45-54.
引用本文的文献
1
Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.患者及普通公众对医生与制药和器械行业互动的认知、信念和态度：一项系统综述
PLoS One. 2016 Aug 24;11(8):e0160540. doi: 10.1371/journal.pone.0160540. eCollection 2016.
2
Public perceptions of physician - pharmaceutical industry interactions: a systematic review.公众对医生与制药行业互动的认知：一项系统综述
Healthc Policy. 2010 May;5(4):69-89.
3
Key personnel and "long distance" settings: determining who must report financial conflict of interest.关键人员和“远距离”设置：确定谁必须报告财务利益冲突。
Account Res. 2010 Jul;17(4):211-22. doi: 10.1080/08989621.2010.493096.
4
The limits of disclosure: what research subjects want to know about investigator financial interests.披露的限度：研究对象想了解的关于研究者经济利益的情况。
J Law Med Ethics. 2006 Fall;34(3):592-9, 481. doi: 10.1111/j.1748-720x.2006.00073.x.
5
Attitudes of academic and clinical researchers toward financial ties in research: a systematic review.学术与临床研究人员对研究中经济利益关系的态度：一项系统综述
Sci Eng Ethics. 2005 Oct;11(4):553-73. doi: 10.1007/s11948-005-0026-z.
6
Potential research participants' views regarding researcher and institutional financial conflicts of interest.潜在研究参与者对研究者和机构财务利益冲突的看法。
J Med Ethics. 2004 Feb;30(1):73-9. doi: 10.1136/jme.2002.001461.
7
[Psychiatrists and the pharmaceutical industry].[精神科医生与制药行业]
Nervenarzt. 2003 Nov;74(11):955-64. doi: 10.1007/s00115-003-1620-4.
8
What do we really know about conflicts of interest in biomedical research?我们对生物医学研究中的利益冲突究竟了解多少？
Psychopharmacology (Berl). 2003 Dec;171(1):36-46. doi: 10.1007/s00213-003-1657-x. Epub 2003 Nov 18.
9
Ethics of undisclosed payments to doctors recruiting patients in clinical trials.向招募患者参与临床试验的医生支付未公开款项的伦理问题。
BMJ. 2002 Jul 6;325(7354):36-7. doi: 10.1136/bmj.325.7354.36.
10
Informed consent to postmarketing research. Patients may feel pressured to participate.对上市后研究的知情同意。患者可能会感到有参与的压力。
BMJ. 1995 Sep 9;311(7006):692. doi: 10.1136/bmj.311.7006.692.
本文引用的文献
1
Physician rewards for postmarketing surveillance (seeding studies) in the US.
Pharmacoeconomics. 1995 Mar;7(3):187-90. doi: 10.2165/00019053-199507030-00001.
2
"How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research.“如果我做志愿者，能得到多少报酬？”关于奖励、同意和研究的机构政策建议。
Hosp Health Serv Adm. 1994 Summer;39(2):193-203.
3
Marketing aspects of company-sponsored postmarketing surveillance studies.公司赞助的上市后监测研究的营销方面
Drug Saf. 1993 Jan;8(1):1-8. doi: 10.2165/00002018-199308010-00001.
4
Evaluating drugs after their approval for clinical use.在药物获批临床使用后对其进行评估。
N Engl J Med. 1993 Dec 30;329(27):2029-32. doi: 10.1056/NEJM199312303292710.
Zotero 插件